Correlation Between Lipocine and Red Branch
Can any of the company-specific risk be diversified away by investing in both Lipocine and Red Branch at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lipocine and Red Branch into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lipocine and Red Branch Technologies, you can compare the effects of market volatilities on Lipocine and Red Branch and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lipocine with a short position of Red Branch. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lipocine and Red Branch.
Diversification Opportunities for Lipocine and Red Branch
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Lipocine and Red is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Lipocine and Red Branch Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Red Branch Technologies and Lipocine is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lipocine are associated (or correlated) with Red Branch. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Red Branch Technologies has no effect on the direction of Lipocine i.e., Lipocine and Red Branch go up and down completely randomly.
Pair Corralation between Lipocine and Red Branch
If you would invest 0.01 in Red Branch Technologies on August 26, 2024 and sell it today you would earn a total of 0.00 from holding Red Branch Technologies or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Lipocine vs. Red Branch Technologies
Performance |
| Timeline |
| Lipocine |
| Red Branch Technologies |
Lipocine and Red Branch Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Lipocine and Red Branch
The main advantage of trading using opposite Lipocine and Red Branch positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lipocine position performs unexpectedly, Red Branch can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Red Branch will offset losses from the drop in Red Branch's long position.| Lipocine vs. Reviva Pharmaceuticals Holdings | Lipocine vs. ZyVersa Therapeutics | Lipocine vs. Unicycive Therapeutics | Lipocine vs. Checkpoint Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Complementary Tools
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |